| 23rd week of 2010 patent applcation highlights part 31 |
| Patent application number | Title | Published |
|---|
| 20100143126 | COOLING SYSTEM AND METHOD FOR WIND TURBINE COMPONENTS - A cooling system and method is provided for a wind turbine. The cooling system is used to cool at least one component in the wind turbine, and includes a filter system having at least one primary filter and at least one secondary filter. A switch selects between the primary filter and the secondary filter. A cooling circuit includes at least one conduit and a coolant medium. The filter system can switch from the primary filter to the secondary filter. | 2010-06-10 |
| 20100143127 | METHOD AND SYSTEM FOR DETERMINING A POTENTIAL FOR ICING ON A WIND TURBINE BLADE - An embodiment of the present invention may provide a method and system for detecting icing on at least one wind turbine blade. An embodiment of the present invention takes the form of a software application and process that utilizes the measure wind speed to detect icing on at least one wind turbine blade. | 2010-06-10 |
| 20100143128 | WIND TURBINE YAW BEARING DETERMINATION - A wind turbine includes a sensor for determining a position indicative of a yaw bearing of the wind turbine. | 2010-06-10 |
| 20100143129 | WIND TURBINE BLADE WITH INTEGRATED STALL SENSOR AND ASSOCIATED METHOD OF DETECTING STALL OF A WIND TURBINE BLADE - A wind turbine includes an electrical stall sensor configured on a pressure surface of at least one turbine blade at a location to detect backflow in a stall condition. The stall sensor includes a flap pivotally configured on the respective pressure surface so as to be moved from a first position towards a second position by backflow over the pressure surface during a stall condition. A sensor circuit responds to movement of the flap between the first and second positions and generates a corresponding electrical signal that indicates the stall condition. | 2010-06-10 |
| 20100143130 | INFLATABLE WIND TURBINE BLADE AND METHOD FOR FORMING SAID ROTOR BLADE - An inflatable rotor blade for a wind turbine includes a flexible skin. The flexible skin assumes, when inflated by means of an inflation medium, the shape of an airfoil which has an inner cavity. When the inner cavity is formed, at least one stiffener unit is arranged in the inner cavity of the rotor blade and maintains the airfoil shape of the flexible skin. | 2010-06-10 |
| 20100143131 | Folding blade turbine - A turbine has airfoils that are configured to extract work from a prevailing fluid flow. An actuator causes the airfoils to pivot or fold between a first position with their spans substantially normal to the flow direction and a second position with their spans substantially parallel to the flow direction, or any position in between. The variable geometry allows the airfoils to be sized for relatively light winds and to remain operational in relatively high winds without damage. Under extreme conditions the airfoils may be folded completely for safety. | 2010-06-10 |
| 20100143132 | TURBINE BLADE WITH REVERSE COOLING AIR FILM HOLE DIRECTION - A gas turbine engine includes turbine blades having film cooling holes at an outer face of an airfoil wherein the film cooling holes are designed to be better filled with air. In a disclosed embodiment, the film cooling holes include a meter section extending along a direction having a main component extending from a blade tip to a blade root. In addition, a diffused section communicates with the meter section at a face of the airfoil. The diffused section is spaced toward the blade tip from the meter section. In this manner, centrifugal force ensures the diffused section is also filled with air. | 2010-06-10 |
| 20100143133 | Vertical Axis Wind Turbine - A vertical axis wind turbine comprising: a rotatable vertical shaft; a first horizontal shaft rotatably attached to the vertical shaft, and extending on either side of the vertical shaft, the first horizontal shaft having a first side on one side of the vertical shaft, and having a second side on an opposite side of the vertical shaft; a first wind turbine blade fixedly attached to the first horizontal shaft on the first side, the first wind turbine extending in a generally perpendicular direction from the first horizontal shaft; a second wind turbine blade fixedly attached to the first horizontal shaft on the second side, the second wind turbine blade extending in a generally perpendicular direction from the first horizontal shaft, the second wind turbine blade fixed at an operational angle with respect to the first wind turbine blade; a first motion limiting means attached to the vertical shaft, and adjacent to the first side of the of the first horizontal shaft, where the first motion limiting means extends into the rotational travel of the first turbine blade; and a second motion limiting means attached to the vertical shaft, and adjacent to the second side of the first horizontal shaft, where the first motion limiting means extends into the rotational travel of the second turbine blade. | 2010-06-10 |
| 20100143134 | METHOD AND APPARATUS FOR USE IN PROTECTING WIND TURBINE BLADES FROM LIGHTNING DAMAGE - A method and apparatus facilitate protecting wind turbine blades from lightning damage. A turbine blade for use with a wind turbine includes a first sidewall and a second sidewall. The second sidewall is coupled to the first sidewall along a leading edge and along an axially-spaced trailing edge such that a cavity is defined between the first and second sidewalls. A relief system is coupled to at least one of the first and second sidewalls. The relief system is configured to discharge flow from the cavity when a pressure within the cavity exceeds a predetermined threshold. | 2010-06-10 |
| 20100143135 | TORSIONALLY LOADABLE WIND TURBINE BLADE - A torsionally loadable wind turbine blade, includes a loading member secured to a body of the wind turbine blade; and an adjuster for actively displacing the loading member and torsionally deforming the blade on a spanwise axis. | 2010-06-10 |
| 20100143136 | SYSTEMS AND METHODS FOR ASSEMBLING A PITCH ASSEMBLY FOR USE IN A WIND TURBINE - A method of assembling a pitch assembly for use in a wind turbine. The method includes coupling a pitch bearing to a hub of the wind turbine, wherein the pitch bearing includes a plurality of bearing teeth. A pitch drive system is coupled to the pitch bearing such that the pitch drive system contacts a first set of bearing teeth. A plurality of bearing segments is coupled to the pitch bearing to cause the pitch drive system to selectively contact a second set of bearing teeth. | 2010-06-10 |
| 20100143137 | Blower wheel - A blower wheel comprising a centerdisk comprising a conical portion ( | 2010-06-10 |
| 20100143138 | Axial flow wind turbine - An axial flow wind turbine having forwardly swept blades with an annular ring interconnecting the blade tips. A rearwardly directed rake profile is also provided together with unequal blade spacing. | 2010-06-10 |
| 20100143139 | BANKED PLATFORM TURBINE BLADE - A turbine blade includes an airfoil and integral platform at the root thereof. The platform is contoured in elevation from a bank adjacent the pressure side of the airfoil to a trough commencing behind the airfoil leading edge. | 2010-06-10 |
| 20100143140 | FLUID FLOW MACHINE WITH SIDEWALL BOUNDARY LAYER BARRIER - A fluid flow machine has a main flow path in which at least one row of blades ( | 2010-06-10 |
| 20100143151 | PERMEABLE ACOUSTIC FLAP FOR WIND TURBINE BLADES - A wind turbine blade includes a permeable flap extending from a trailing edge of the blade. | 2010-06-10 |
| 20100143152 | METHOD AND APPARATUS FOR INCREASING LIFT ON WIND TURBINE BLADE - A lift device for a wind turbine blade. The lift device includes a first sidewall and an opposing second sidewall. The lift device is configured to be coupled to the wind turbine blade along a leading edge of the wind turbine blade, and to generate lift when airflow is directed across a surface of the lift device. | 2010-06-10 |
| 20100143153 | TURBINE BLADE - A turbine blade comprising at least one cooling element, a cooling duct for conducting a cooling medium, and a leading edge is provided. The cooling element is located within the flow of the cooling medium and is designed in a cog-shaped manner. The cooling duct is formed within the turbine blade for conducting a cooling air flow and extends along the flow attacking edge in at least some sections. The cooling elements are successively arranged in a stationary manner inside the cooling duct in the longitudinal direction. Each individual cooling element has a cooling capacity that is adapted to a predefined cooling requirement for the leading edge in the vicinity of the cooling element. | 2010-06-10 |
| 20100143154 | SPACER FOR GAS TURBINE BLADE INSERT - A gas turbine blade has: a main hollow body substantially extending along a longitudinal axis and having a leading edge, a trailing edge, opposite to the leading edge, a suction side, and a pressure side, both comprised between the leading edge and the trailing edge; a hollow cooling element extending along the axis, which is equipped with a plurality of cooling holes and is set within the main body so as to define a gap between the main body and the cooling element; and a rib, which is set within the gap for connecting the main body with the cooling element on the suction side, in an area of the main body without holes for communication between the gap and the outside of the blade. | 2010-06-10 |
| 20100143155 | Piston Pump Having A Force Sensor And A Method For Controlling Said Pump - The present invention relates to a piston pump for generating a delivery flow, which is substantially free of pulsation, in particular to a dual piston pump, and to a method for controlling such a piston pump delivering a pumped medium from a low-pressure area into a high-pressure area, wherein measuring sensors detecting mechanical forces or moments transmitted by the structure of the pump or its associated drive unit are used instead of the pressure or flow sensors usually employed for this purpose. | 2010-06-10 |
| 20100143156 | Fail-Safe Control Method for Oil Pump Control Unit of Hybrid Vehicle - A fail-safe control method for an oil pump control unit of a hybrid vehicle directly connects an automatic transmission control unit and an oil pump control unit via a hard wire to control an oil pump driver in the event of a failure of the CAN communication line of the oil pump control. It enables the rotation speed of a motor of the electric oil pump to be controlled by a motor control unit (MCU) or a underdrive brake (UD_BRAKE) to be controlled in on/off mode or in slip mode by the automatic transmission control unit until a mechanical oil pump is driven, in the event of a failure of the oil pump control unit or the electric oil pump. | 2010-06-10 |
| 20100143157 | METHOD AND SYSTEM FOR DETECTING CAVITATION OF PUMP AND FREQUENCY CONVERTER - A method and a system are disclosed in accordance with a pump controlled with a frequency converter. An exemplary method includes controlling the pump with a frequency converter, the frequency converter feeding a motor connected to drive the pump, providing a torque estimate (T | 2010-06-10 |
| 20100143158 | Variable speed air compressing system - A variable speed air compressing system includes a compressor, a motor configured to actuate the compressor, and a rectifier configured to receive alternating current from a first power source and to provide rectified direct current having a first voltage. The system also includes an inverter configured to receive the rectified direct current and to receive direct current from a second power source having a second voltage. The inverter is configured to provide alternating current to the motor. The alternating current provided to the motor is based on the rectified direct current if the first voltage is greater than the second voltage and the alternating current is based on the direct current from the second power source if the second voltage is greater than the first voltage. | 2010-06-10 |
| 20100143159 | ION PUMP DEVICE - The above-mentioned problem is solved by an ion pump ( | 2010-06-10 |
| 20100143160 | SUBMERSIBLE PUMP MOTOR COOLING THROUGH EXTERNAL OIL CIRCULATION - An electrical submersible pump motor has motor oil flowing through external circulation tubes for cooling the motor. A substantial portion of the exterior of each tube is submerged in and exposed to wellbore fluid. Heat is transferred from the motor to the motor oil, and then circulated through the external circulation tubes to conduct heat to the wellbore fluid. Internal or external motor oil pumps may be used to propel the motor oil through the circulation tubes. Guards or baffles may be used to protect the circulation tubes and to influence the flow of production fluid over he circulation tubes. | 2010-06-10 |
| 20100143171 | CONTROL DEVICE FOR A HYDRAULIC PISTON MACHINE WITH A VARIABLE FLOW RATE - The invention relates to a control device for a hydraulic piston machine which can be embodied as a hydropump or a hydromotor and the time-averaged volume flow of which is variable. The piston machine comprises a plurality of pistons, each delimiting a working chamber the volume of which varies with the stroke of a piston and which can be connected to a high pressure port via a first valve and to a low pressure port via a second valve. At least one of the two valves of a working chamber can be actively electrically actuated. The control device comprises an electronic control unit which operates the actively actuated valves of the working chambers in a partial stroke mode, in which only a varying portion of the piston stroke is utilized. In order to reduce the control complexity, the actively actuated valves can be operated in not more than two different modes, namely either only in the partial stroke mode or in the partial stroke mode and an idle stroke mode or in the partial stroke mode and a complete stroke mode or all three modes can only be applied to a limited number of working chambers and only the idle stroke mode and the complete stroke mode to the remaining working chambers. | 2010-06-10 |
| 20100143172 | Multistage Compressor - A multistage compressor employing a gas injection system for CO | 2010-06-10 |
| 20100143173 | DUAL-PLATE SWASH PUMP - A swash-plate machine for pumping fluids uses dual swash plates in complementary or mirror-image orientation. The vibration that is generated as a reaction to forced nutatory motion imposed on a single swash plate is thereby largely cancelled. Rotated orientation of the divider plate position in one chamber with respect to the other (preferably 90 degrees difference) provides four outputs per revolution instead of the two available from both sides of a single swash plate. Improved bearings for the part-spherical swash plate base permits only oscillatory movement for that part and facilitate better sealing. | 2010-06-10 |
| 20100143174 | Rotary Working Machine Provided with an Assembly of Working Chambers and Periodically Variable Volume, In Particular a Compressor - A rotary working machine is provided. The machine includes an assembly of working chambers with periodically variable volume disposed in a central block defining a stator. The inside surfaces of the stator direct a pendulum motion of one or more blade-type working elements disposed in respective one or more cylindrical sockets of a cylindrical rotator that is disposed within an interior of the camshaft form stator. The rotator is connected to an external prime mover for providing torque thereto. An angle of contact between a front cylindrical surface of the blade-type working elements and the internal curved space of the camshaft form stator defines a working chamber of variable volume, the working chamber of variable volume is connected during rotator revolution correspondingly with an inside pipe of a camshaft and an annular slot that is configured to evacuate compressed gas disposed within the working chamber of variable volume. The outline of a cross-sectional of opening of the camshaft form stator disposed in a vertical plane to with respect to an axis of the cylindrical rotator constitutes the equidistant line to a curve that is described on an immobile plane perpendicular to the axis of the cylindrical rotators by a Radziwill curve. A defined relationship exists between the rotation angle of the cylindrical rotator and the deflection angle of an axis of the working element/ | 2010-06-10 |
| 20100143175 | INTERNAL GEAR PUMP WITH OPTIMIZED NOISE BEHAVIOUR - An internal gear pump ( | 2010-06-10 |
| 20100143176 | METHOD OF PRODUCING TITANIUM ALLOY COMPOSITE MATERIAL - A method of producing a titanium alloy composite material comprises mixing carbon fibers and a powder of an element which forms a carbide in reaction with carbon, subliming the element under high temperature vacuum, and coating the carbon fibers with a layer containing the element and the carbide to produce coated carbon fibers. The method further comprises mixing the coated carbon fibers and titanium alloy powder to form a mixture, and applying a mechanical impact force to the mixture to fix the carbon fibers on the surface of the titanium alloy powder to obtain a carbon fiber-fixed titanium alloy powder. The method further comprises sintering the carbon fiber-fixed titanium alloy powder to form a sintered body and plastic working the sintered body to disperse the carbon fibers in crystal grains of the titanium alloy. | 2010-06-10 |
| 20100143177 | Method for forming high strength aluminum alloys containing L12 intermetallic dispersoids - A method and apparatus produces high strength aluminum alloys from a powder containing L1 | 2010-06-10 |
| 20100143178 | ALLOY CONTAINING RARE EARTH ELEMENT, PRODUCTION METHOD THEREOF, MAGNETOSTRICTIVE DEVICE, AND MAGNETIC REFRIGERANT MATERIAL - An RE-containing alloy, which is represented by a compositional formula of R | 2010-06-10 |
| 20100143179 | LEAD FREE FREE-CUTTING STEEL AND ITS USE - A lead free free-cutting steel is described having the following composition in percent by weight: C 0.85-1.2 Si 0.1-0.6 Mn 0.4-1.2 P max 0.05 S 0.04-0.3 Cr max 2 Ni max 1 Mo max 0.5 Cu max 2 Al max 0.1 B max 0.008 Bi+Se+Te max 0.005 Ti+Nb+Zr+V max 0.2 balance Fe and normally occurring impurities. The steel is mainly intended for small/thin dimensions and/or low cutting speeds during manufacture of a product formed of the steel. | 2010-06-10 |
| 20100143180 | HOT-FORGING MICRO-ALLOYED STEEL AND HOT-ROLLED STEEL EXCELLENT IN FRACTURE-SPLITABILITY AND MECHINABILITY, AND COMPONENT MADE OF HOT-FORGED MICROALLOYED STEEL - The invention provides a hot-forging micro-alloyed steel and a hot-rolled steel which achieve excellent fracture-splitability and machinability, without impairing productivity or mechanical properties and without addition of Pb or the like. It also provides a component made of hot-forged micro-alloyed steel. | 2010-06-10 |
| 20100143181 | High strength austenitic trip steel - An austenitic TRIP steel consisting essentially of, in weight %, 0.14 to 0.18% Al, 2.8 to 3.2% Ti, 23.5 to 23.8% Ni, 3.8 to 4.2% Cr, 1.1 to 1.3% Mo, 0.29 to 0.31% V, 0.01 to 0.015% B, 0.01 to 0.02% C, and balance Fe and incidental impurities exhibits combined high yield strength and high strain hardening leading to improved stretch ductility under both tension and shear dynamic loading conditions. | 2010-06-10 |
| 20100143182 | Ni-BASED SINGLE CRYSTAL SUPERALLOY - A Ni-based single crystal superalloy according to the invention has, for example, a composition including: 5.0 to 7.0 wt % of Al, 4.0 to 10.0 wt % of Ta, 1.1 to 4.5 wt % of Mo, 4.0 to 10.0 wt % of W, 3.1 to 8.0 wt % of Re, 0.0 to 2.0 wt % of Hf, 2.5 to 8.5 wt % of Cr, 0.0 to 9.9 wt % of Co, 0.0 to 4.0 wt % of Nb, and 1.0 to 14.0 wt % of Ru in terms of weight ratio; and the remainder including Ni and incidental impurities. In addition, the contents of Cr, Hf and Al are preferably set so as to satisfy the equation OP≧108. According to the Ni-based single crystal superalloy of the invention, high creep strength can be maintained and the oxidation resistance can be improved. | 2010-06-10 |
| 20100143183 | PROCESS FOR MANUFACTURE OF NANOMETRIC, MONODISPERSE, STABLE METALLIC SILVER AND A PRODUCT OBTAINED THEREFROM - The present invention relates to a procedure for preparation by a wet reduction method of nanometric particles of metallic silver, with diameter ranging from 1 to 100 nm and an average diameter of 20 to 40 nm, with monodispersion characteristics, stabilities exceeding 12 months and in a wide range of concentrations. The process comprises 4 stages: a) preparation of the reducing agent solution, taken from the tannins group and preferably tannic acid; b) preparation of a solution of soluble silver salts; c) reaction and, d) liquid-solid separation; the particle size is determined by the nature of the reducing agent and by the pH control of the currents. The final stage is designed for separating and concentrating the material after which the user can prepare the product for integration thereof in the desired medium. The particles obtained are redispersable in different media, such as water, alkidalic and phenolic resins, nitrocellulose, polyeurethane, vinylics, acrylics, alcohols, and in a wide range of organic and polymeric products such as high and low density polyethylene, Nylon, ABS and/or mixtures thereof. | 2010-06-10 |
| 20100143184 | METHOD FOR MANUFACTURING METAL NANORODS AND USE THEREOF - A method for manufacturing metal nanorods includes: a step of adding a reducing agent to a metallic salt solution; a step of radiating light into the metallic salt solution containing the reducing agent; and a step of leaving the light-radiated metallic salt solution containing the reducing agent stationary in a dark place so as to grow metal nanorods. Metal nanorods can be also grown by forming a mixed solution by fractionating the above light-radiated metallic salt solution and mixing the fractionated metallic salt solution into a non-radiated metallic salt solution containing the reducing agent, or mixing a non-radiated metallic salt solution and the reducing agent into the above light-radiated metallic salt solution; and leaving the mixed solution stationary in a dark place so as to grow metal nanorods. | 2010-06-10 |
| 20100143185 | Method for producing high strength aluminum alloy powder containing L12 intermetallic dispersoids - A method for producing high strength aluminum alloy powder containing L1 | 2010-06-10 |
| 20100143186 | Dispensing Device for Air Treatment Agents - The present invention relates to a dispensing device for at least one air treatment agent comprising at least one airborne agent detector operable to detect airborne agents in the air; receiving means for receiving at least one source of air treatment agent; and control means for releasing an amount of at least one air treatment agent from a source thereof received in the receiving means when a current airborne agent level detected by the airborne agent detector deviates from a background airborne agent level detected by the airborne agent detector by more than a predetermined amount, wherein the background airborne agent level is calculated by the device. The present invention also relates to a method of dispensing at least one air treatment agent. | 2010-06-10 |
| 20100143187 | DRINKING WATER SYSTEMS MONITORING AND CLEANING METHOD - A method for determining the relative level of contamination of a component in a water treatment infrastructure is disclosed. The method includes the steps of at least partially filling the component with water; isolating the component from the remainder of the infrastructure; taking a control water sample from the component at a point in time T | 2010-06-10 |
| 20100143188 | UV STERILIZER - A UV steriliser for oral appliances comprising, (a) a base including a UV source, (b) a lid, and (c) an appliance holder intermediate the lid and the base, the appliance holder being adapted to hold the oral appliance adjacent the UV source, wherein pressure exerted on the appliance holder can activate the UV source. | 2010-06-10 |
| 20100143189 | METHOD AND APPARATUS FOR DECONTAMINATING ENCLOSED SPACES - The disclosure relates to an apparatus ( | 2010-06-10 |
| 20100143190 | SYSTEM FOR ENRICHING A BODILY FLUID WITH A GAS HAVING OCCLUSION DETECTION CAPABILITIES - This invention discloses a modular system having a base module, a mid-section control module, and a display module for preparing and administering a gas-enriched bodily fluid via an extracorporeal circuit. Gas-enrichment is achieved by a gas-enriching device which can be in the form of a disposable cartridge. During operation, the gas-enrichment device is placed in an enclosure within the control module. An electronic controller manages the various aspects of the system such as the production of gas-enriched fluid, flow rates, bubble detection, and automatic operation and shut down. The controller is capable of detecting occlusions in the extracorporeal circuit and responding to different occlusion conditions to prevent forced shutdown/re-priming of the circuit. | 2010-06-10 |
| 20100143231 | Method and Apparatus for Manufacturing Silicon Ingot - Provided are a novel method and novel apparatus for manufacturing a silicon ingot that make it possible to reduce manufacturing steps and also reduce required electric power. A method for manufacturing a silicon ingot, including the step of heating and melting, in a crucible, an element which can undergo eutectic reaction with silicon and has a lower eutectic point than the melting point of silicon when made into silicon alloy, and a metallic silicon, thereby generating an alloy melt, and the step of using the eutectic reaction for the alloy melt to subject the silicon to low-temperature solidification refinement, and further producing the silicon ingot from the alloy melt by a pulling method is provided. | 2010-06-10 |
| 20100143232 | METAL BINARY AND TERNARY COMPOUNDS PRODUCED BY CATHODIC ARC DEPOSITION - The present invention allows the relatively easy production of binary and ternary compounds of metals, including noble metals. Embodiments of the invention allow, for the first time, the production of novel compositions of metal compounds, such as thick, stress-free single-phase binary and ternary compositions of metals, and porous compositions of such compounds. As such, the present invention allows for the production of metal compounds and/or compositions of matter thereof that have not before been possible, thereby providing for important new materials that find use in a multitude of different applications, including medical device and non-medical device applications. | 2010-06-10 |
| 20100143233 | METHOD FOR PREPARING CERIUM CARBONATE POWDER - In a method for preparing cerium carbonate powder by mixing a cerium precursor solution with a carbonate precursor solution and carrying out a precipitation reaction, wherein cerium carbonate is controlled to have an orthorhombic crystal structure, a hexagonal crystal structure or an orthorhombic/hexagonal mixed crystal structure, by using at least one type of organic solvent comprising at least two hydroxyl groups (OH) in molecular formula as a solvent for either or both the cerium precursor solution and the carbonate precursor solution, and varying a number of carbons or hydroxyl groups (OH) included in the molecular formula of the organic solvent. The method can easily and inexpensively obtain cerium carbonate powder with a desired crystal structure without the danger by high-temperature high-pressure and the need for an expensive system in hydrothermal synthesis. | 2010-06-10 |
| 20100143234 | METHODS OF PREPARING AND PURIFYING CARBON NANOTUBES, CARBON NANOTUBES, AND AN ELEMENT USING THE SAME - A method of preparing carbon nanotubes (CNT), a method of purifying carbon nanotubes, carbon nanotubes, and an element using said carbon nanotubes are provided. The method includes preparing carbon nanotubes by arc-discharge and employs a coordination chemistry process to remove a catalyst and/or optional promoter used in arc-discharge. | 2010-06-10 |
| 20100143235 | Method of manufacturing carbon nanofiber and apparatus for manufacturing the same - The present invention provides a method of manufacturing a carbon nanofiber of the present invention including dissolving a catalyst-precursor and a supporter-precursor into a solvent of a hydrocarbon-based compound to prepare a reacting solution, atomizing the reacting solution, thermally decomposing the atomized reacting solution to forming particles of the carbon nanofiber, and collecting the particles of the carbon nanofiber. In accordance with the above method, the carbon nanofiber is efficiently mass-produced in situ process and in batch process. | 2010-06-10 |
| 20100143236 | Preparation of hydrogen fluoride from calcium fluoride and sulfuric acid - Calcium fluoride fines or residues comprising calcium fluoride fines, e.g. residues from treating waste water or waste gas, e.g. originating from HF or fertilizer production, with calcium oxide or calcium carbonate to remove HF or fluorides can be converted to HF and calcium sulfate by reaction with sulfuric acid in the form of a suspension. Unreacted calcium oxide or calcium carbonate generates sufficient heat to the endothermic reaction between calcium fluoride and sulfuric acid so that no external heat is needed. | 2010-06-10 |
| 20100143237 | A Method of Treating Potash - A method of separating potassium chloride and sodium chloride from a heated solution of these salts, such as a solution obtained from potash ore, to recover potassium chloride from the ore is disclosed. The method includes a combination of steps of (a) extracting water from a heated solution containing potassium chloride and sodium chloride using a membrane system and (b) subsequently cooling the solution discharged from the membrane system, whereby steps (a) and (b) make it possible to selectively recover potassium chloride and sodium chloride from the solution. | 2010-06-10 |
| 20100143238 | PROCESSES FOR CONJOINTLY PRODUCING BROMINE, CALCIUM CHLORIDE, AND CHLORINE - Processes are provided for conjointly producing Br | 2010-06-10 |
| 20100143239 | METHOD FOR PARALLEL OPERATION OF REACTORS THAT GENERATE MOISTURE - The method for parallel operation of moisture generating reactors according to the present invention operates so that an orifice, provided with an orifice hole having a predetermined opening diameter, is disposed on a mixed-gas inlet side of each of a plurality of moisture generating reactors connected in parallel with each other, and mixed gas G consisting of hydrogen and oxygen is supplied from a mixer to each of the moisture generating reactors through each orifice, and the flows of moisture generated by the moisture generating reactors are combined, and the resulting combined moisture is supplied to an apparatus that uses high-purity water. Thus, a need to increase the amount of high-purity water supply is met by allowing a plurality of moisture generating reactors to perform a parallel water generating operation by branching off a mixed gas consisting of H | 2010-06-10 |
| 20100143240 | Method for generation of hydrogen gas - A method for generation of hydrogen with reduced foaming by combining with water a solid composition containing a borohydride compound and a base in the presence of a transition metal catalyst. | 2010-06-10 |
| 20100143251 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 2010-06-10 |
| 20100143252 | IMAGING 18F OR 11C-LABELLED ALKYLTHIOPHENYL GUANIDINES - The invention provides a compound of formula (I); or a salt or solvate thereof, wherein: R | 2010-06-10 |
| 20100143253 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 2010-06-10 |
| 20100143254 | MOLECULES WITH REDUCED HALF-LIVES, COMPOSITIONS AND USES THEREOF - The present invention provides polypeptides containing at least the FcRn binding portion of an Fc region of an immunoglobulin molecule and that have altered amino acid sequences relative to wild type immunoglobulin molecules. The polypeptides have decreased in vivo serum half-lives and can be employed in various methods. | 2010-06-10 |
| 20100143255 | FIG4 GENE MUTATIONS IN NEURODEGENERATION - The present invention relates to neuropathy, in particular to mutations in the FI G4 gene. The present invention also provides assays for the detection of variant FIG4 alleles, and assays for detecting FIG4 polymorphisms and mutations associated with disease states. | 2010-06-10 |
| 20100143256 | ELECTROENCEPHALOGRAPHY BASED SYSTEMS AND METHODS FOR SELECTING THERAPIES AND PREDICTING OUTCOMES - A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users. | 2010-06-10 |
| 20100143257 | Prevention of Cancers by Immunization - In healthy subjects, especially the ones with increased risk for developing cancer due to genetic predisposition or other risk factors, cancer can be prevented by immunization with a cancer vaccine. Oncoantigens present in the vaccine preferably are incubated with IFN-γ, IL-2 or both. To prevent cancer recurrence, cancer patients in remission are given a prolonged course of immunizations with a vaccine that includes, for example, oncoantigens in combination with immune competent cells (e.g., bone marrow and T lymphocytes). The bone marrow and T lymphocytes are optionally treated with IFN-γ, IL-2 or both. | 2010-06-10 |
| 20100143258 | TUMOR MARGIN IMAGING AGENTS - In one aspect, the present invention provides a functionalized monodisperse polylysine comprising a linear monodisperse polylysine chain comprising constituent lysine monomer residues containing appended C | 2010-06-10 |
| 20100143259 | FLUORESCENT MICROSPHERES, THE PREPARATION METHOD AND USES THEREOF - The invention discloses the microspheres comprising the following structure in the composition thereof and the uses as tracers and fluorescent standard calibration products. | 2010-06-10 |
| 20100143260 | COATING SYSTEM - Embodiments of the invention include a system comprising: an Acetoxy curable silicone Binder; and an active agent blended with the silicone binder, effective for one or more of radiopacification, lubricity, elution of a secondary compound such as a drug, echogenic properties, thermal or electrically insulative properties or chemical indicators wherein the silicone binder effectiveness is not substantially changed by the active agent. | 2010-06-10 |
| 20100143261 | COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCS - Provided is a gene therapy composition for transferring one of a therapeutical gene, a maker gene, or a mixture thereof to a cell that expresses interleukin-8(IL-8) or GRO-α and induces tropism of mesenchymal stem cells isolated from umbilical cord blood and/or the mesenchymal stem cells expanded from said mesenchymal stem cells (UCB-MSCs), wherein the cell-treating composition includes UCB-MSCs. Provided is a composition for treating disease related to a cell expressing IL-8 or GRO-α, that is, a brain tumor in gene therapy, by using UCB-MSCs. Provided is a composition or kit for diagnosing brain tumors, preventing brain tumors, treating brain tumors, or monitoring brain tumor treatment progression by using UCB-MSCs. | 2010-06-10 |
| 20100143262 | Method for Identifying Allergenic Proteins And Peptides - A method for identifying allergenic proteins and peptides. More specifically, a method for identifying allergenic milk proteins and/or peptides including the steps of: providing at least one expression library comprising DNA or cDNA derived from the mammary gland tissue of a lactating cow, expressing at least one protein or peptide encoded by said expression library, determining the binding capacity of said at least one protein or peptide to IgE of at least one serum of an individual who is sensitive to cow's milk, contacting the at least one protein or peptide exhibiting an IgE binding capacity as determined in step c) with basophil cells, eosinophil cells or mast cells and identifying the at least one protein or peptide as being allergenic when said basophil cells, eosinophil cells or mast cells release upon contact with at least one protein or peptide of step d) at least one mediator. | 2010-06-10 |
| 20100143263 | MAGNETIC RESONANCE IMAGING CONTRAST AGENTS COMPRISING ZINC-CONTAINING MAGNETIC METAL OXIDE NANOPARTICLES - The present invention relates to an MRI contrast agent that includes zinc-containing water-soluble metal oxide nanoparticles and has an improved contrast effect. The zinc-containing water-soluble metal oxide nanoparticles are characterized by addition of zinc to a matrix comprising the metal oxide nanoparticles or by substitution of metal in the matrix, resulting in the improved contrast effect of MRI. In addition, the zinc-containing metal oxide nanoparticles of the present invention include the MRI contrast agent t having hybrid structures of “zinc-containing metal oxide nanoparticle—biologically/chemically active material” in which the nanoparticle is conjugated with a bioactive material such as proteins, antibodies, and chemical materials. | 2010-06-10 |
| 20100143264 | COMPOSITIONS FOR AEROSOLIZATION OF HIGHLY CONDUCTIVE SOLUTIONS - Compositions for aerosolization of conductive solutions (preferably highly conductive solutions) by way of electrostatic or electrohydrodynamic spraying are provided. Methods for making and using these compositions and electrostatic and electrohydrodynamic aerosol generators containing these compositions are also provided. | 2010-06-10 |
| 20100143265 | SYSTEM AND METHOD FOR THE DELIVERY OF A SANITIZING FOAM - A spray solution generates a foam to sanitize surfaces. The spray dip solution is a mixture of the solution with carbon dioxide and nitrous oxide in a closed vessel. After ejecting the liquid dip solution mixture from a nozzle a foam is generated from the solution as the solution hits a surface. The spray can be applied to a number of different surfaces. In an embodiment of the invention, the spray can be applied to cow teats without risk of cross-contamination of the nozzle or other equipment. The generated foam remains intact on the teat for a prolonged period of time, increases the area of the teat in contact with the foam during the treatment period and disperses skin-conditioning fats present in the dip treatment, thereby increasing the coverage of the skin conditioner on and within the epidermis of the teat and surrounding areas. | 2010-06-10 |
| 20100143266 | METHODS FOR REDUCING ALLERGIES CAUSED BY ENVIRONMENTAL ALLERGENS - Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided. | 2010-06-10 |
| 20100143267 | EXTRACTS OF TETRASELMIS SP. - The present invention relates to extracts of | 2010-06-10 |
| 20100143268 | Formulations for Delivery Via Pressurised Metered Dose Inhalers Comprising an Essential Oil as Suspension Stabiliser - A formulation suitable for delivery from a pressurised metered dose inhaler comprises a hydrofluoroalkane liquid, which is pharmaceutically acceptable, for instance HFA 134a or HFA 227, a drug to be delivered to the lung which is insoluble in the hydrofluoroalkane, the drug being in particulate form in the composition, further containing a suspension stabiliser which is a non-toxic essential oil miscible with the hydrofluoroalkane liquid at room temperature. The essential oil is preferably one having some amphiphilic property, such as a ketone or aldehyde compound. Insulin may be formulated for inhalation. | 2010-06-10 |
| 20100143269 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA - Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same. | 2010-06-10 |
| 20100143270 | THERAPEUTIC COTININE COMPOSITIONS - The present invention provides methods and compositions for treating acute and/or chronic inflammation with cotinine or a pharmaceutically acceptable salt thereof. | 2010-06-10 |
| 20100143271 | Method for preparing amorphous calcium phosphate and oral care composition containing amorphous calcium phosphate prepared by the same - A method for preparing amorphous calcium phosphate (ACP) and oral care composition containing ACP prepared by the same are disclosed, wherein the method comprises the following steps: (a) cleaning and pulverizing the oyster shells; (b) sintering the oyster shells to obtain a calcium-containing powder; (c) dissolving the calcium-containing powder in water to obtain a calcium-containing solution; and (d) mixing the calcium-containing solution with a other phosphate-containing solution, to produce amorphous calcium phosphate. | 2010-06-10 |
| 20100143272 | Photo-stable cosmetic or dermatological compositions - Disclosed is the use of an effective photo-stabilizing amount of stabilizing agent (a) selected from a diphenylacrylate UV filter (a | 2010-06-10 |
| 20100143273 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT - The present application relates to a cosmetic composition comprising, in a physiologically acceptable medium, at least one aprotic hydrocarbon-based volatile solvent comprising no more than one branch, the volatility of said solvent being such that the amount evaporated in 30 minutes is between 4.1 mg/cm | 2010-06-10 |
| 20100143274 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS - Disclosed is the use of amines and amides for the stabilization of a cosmetic composition comprising: (a) an organic micronized UV absorber selected from a benzophenone derivative and (b) a dibenzoylmethane derivative. The use of the amines and amides results in the stabilization of the end-product formulations. | 2010-06-10 |
| 20100143275 | Canola Extracts Containing High Levels of Phenolic Acids - Disclosed in certain embodiments is a canola extract comprising greater than 30% sinapic acid, pharmaceutical compositions thereof, and methods thereof | 2010-06-10 |
| 20100143276 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions - Stable UV-screening cosmetic compositions contain at least one ester solvent derived from 4-carboxy-2-pyrrolidinone, of formula (I): | 2010-06-10 |
| 20100143277 | Skin Lightening Compositions with Acetylcholinesterase Inhibitors - Skin lightening additives and skin lightening compositions having an acetylcholinesterase inhibitor are described. The compositions are suitable for topical application and may comprise inhibitors like galanthamine, taspine or both. | 2010-06-10 |
| 20100143278 | Low-residue deodorant or antiperspirant stick based on an oil-in-water emulsion - Deodorant or antiperspirant sticks based on an oil-in-water dispersion for application to the skin. | 2010-06-10 |
| 20100143279 | COSMETIC/DERMATOLOGICAL COMPOSITIONS COMPRISING A DERIVATIVE OF GLUCOSE AND OF VITAMIN F AND A SPECIFIC SURFACTANT - Topically applicable cosmetic/dermatological compositions suited for improving the condition of human keratin fibers, notably human hair, especially for reducing or stopping loss and/or inducing and/or stimulating growth and/or density thereof, contain a thus effective amount of (a) at least one derivative of glucose and of vitamin F, solubilized in a topically applicable, physiologically acceptable medium therefor which includes (b) at least one nonionic surfactant having a hydrophilic/lipophilic balance (HLB) of greater than 10, (c) at least one C | 2010-06-10 |
| 20100143280 | Method for Preparing Personal Care Composition Comprising Surfactant and High Melting Point Fatty Compound - Disclosed is a method of preparing a personal care composition, comprising the steps: (1) preparing a hot oil phase comprising the surfactant and the high melting point fatty compound; (2) preparing a cold aqueous phase comprising the aqueous carrier; and (3) mixing the oil phase and the aqueous phase to form an emulsion; wherein the mixing step (3) comprises the following detailed steps: (3-1) feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0×10 | 2010-06-10 |
| 20100143311 | ANTICANCER THERAPY BY TRANSPLANTING VASCULAR ENDOTHELIAL PROGENITOR CELLS - It is intended to provide anticancer therapy using autologous cells or the like, which induces the regression of cancer or has favorable drug delivery effects and brings about reduction or withdrawal of a hypoxic region(s) in tumor. Transplantation of endothelial progenitor cells, via intravenously or other methods leads to tumor growth inhibition, an increase of the vascular density with an enlargement of the vascular diameter, and reduction of a hypoxic region(s) in the tumor. Allogeneic transplantation of endothelial progenitor cells may be achieved to secure the cells for the therapy, however, autologous transplantation of endothelial progenitor cells from cancer patients would be desirable in order to evade rejection. When the autologous cells are used, mononuclear cells are separated from the peripheral blood or bone marrow of the patient and cultured using an endothelial differentiation medium containing cytokines such as VEGF to obtain adherent cells, which can then be collected and advantageously used as endothelial progenitor cells. | 2010-06-10 |
| 20100143312 | TREATMENT OF DISEASES, DISORDERS OR CONDITIONS OF THE LUNG USING PLACENTAL CELLS - Provided herein are compositions and methods of treatment of individuals having a disease, disorder or condition of the lung, comprising administering a therapeutically-effective amount of placental cells, e.g., placental stem cells. | 2010-06-10 |
| 20100143313 | HOMOGENEOUS DIFFERENTIATION OF HEPATOCYTE-LIKE CELLS FROM EMBRYONIC STEM CELLS - One of the major hurdles of cellular therapies for the treatment of liver failure is the low availability of functional human hepatocytes. Although embryonic stem (ES) cells represent a potential cell source for therapy, current methods for differentiation result in mixed cell populations or low yields of the cells of interest. The present invention provides for a rapid, direct differentiation method that yields a homogeneous population of endoderm-like cells with 95% purity. In one embodiment, mouse ES cells cultured on top of collagen-sandwiched hepatocytes differentiate and proliferate into a uniform and homogeneous cell population of endoderm-like cells. The endoderm-like cell population was positive for Foxa2, Sox17 and AFP, and could further differentiate into hepatocyte-like cells that demonstrate hepatic morphology, functionality, and gene and protein expression. Incorporating the hepatocyte-like cells into a bioartificial liver device to treat fulminant hepatic failure improved animal survival, thereby underscoring the therapeutic potential of these cells. | 2010-06-10 |
| 20100143314 | In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy - The present invention relates to transfected primary and secondary somatic cells of vertebrate origin, particularly mammalian origin, transfected with exogenous genetic material (DNA) which encodes erythropoietin or an insulinotropin [e.g., derivatives of glucagon-like peptide 1 (GLP-1)], methods by which primary and secondary cells are transfected to include exogenous genetic material encoding erythropoietin or an insulinotropin, methods of producing clonal cell strains or heterogenous cell strains which express erythropoietin or an insulinotropin, methods of gene therapy in which the transfected primary or secondary cells are used, and methods of producing antibodies using the transfected primary or secondary cells. The present invention also includes primary and secondary somatic cells, such as fibroblasts, keratinocytes, epithelial cells, endothelial cells, glial cells, neural cells, formed elements of the blood, muscle cells, other somatic cells, which can be cultured and somatic cell precursors, which have been transfected with exogenous DNA encoding EPO or an insulinotropin, which is stably integrated into their genomes or is expressed in the cells episomally. | 2010-06-10 |
| 20100143315 | Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof - The present invention relates to a method for producing a cell line expressing a stabilized functional single chain-antigen-recognizing genetic construct (scARC), comprising a genetic construct of the human scARC to be expressed, comprising the domains huV | 2010-06-10 |
| 20100143316 | NOVEL STRAIN OF BACILLUS AMYLOLIQUEFACIENS AND ITS USE - An isolated | 2010-06-10 |
| 20100143317 | INFARCT AREA PERFUSION-IMPROVING COMPOSITIONS AND METHODS OF VASCULAR INJURY REPAIR - The described invention provides pharmaceutical compositions for treating an infarct area injury and methods of treating or repairing the infarct area injury in a revascularized subject in the aftermath of an acute myocardial infarction resulting from a natural disease process by administering to the subject parenterally through a catheter a sterile pharmaceutical composition containing a therapeutically effective amount of a nonexpanded sterile isolated chemotactic hematopoietic stem cell product as a first therapeutic agent and optionally a therapeutically effective amount of at least one compatible second therapeutic agent. The infarct area-improving amount of the sterile isolated chemotactic hematopoietic stem cell product comprises an enriched population of isolated autologous CD34+ cells containing a subpopulation of potent cells expressing CXCR-4 and having CXCR-4-mediated chemotactic activity such that the enriched population of isolated autologous CD34+ hematopoietic stem cells provides at least 0.5×10 | 2010-06-10 |
| 20100143318 | GSTP1 AS TERATOGENIC ALLELE FOR AUTISM AND ASSAYS AND METHODS BASED THEREON - The present invention provides novel markers and assays for autism based on the association of GSTP1 with prevalence for having a child or children with autism or autistic disease. The invention relates to the use and application of GSTP1 as a susceptibility marker and teratogenic allele for autism. In particular the genotype of GSTP1 at amino acids 105 and 114, corresponding to nucleotides 313 and 341 are determined. GSTP1 may be combined with other markers in methods and assays for monitoring, managing, diagnosis, prenatal diagnosis, and assessment of autism. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with autism wherein the genotype of GSTP1, alone or in combination with other genetic markers or other indicators of oxidative stress, is determined. | 2010-06-10 |
| 20100143319 | KIWIFRUIT COMPOSITIONS - Extracts derived from kiwifruit are particularly useful for managing gut health and for treating or preventing digestive dysfunction and/or gastrointestinal tract disorders. In one aspect the extracts include an effective amount of prebiotic material derived from kiwifruit of the species | 2010-06-10 |
| 20100143320 | DIETARY SUPPLEMENT - The invention relates to a dietary supplement that promotes proper ingestion and proper digestion of animal and/or vegetable proteins. The supplement comprises an enzyme mixture containing amylase, lactase and bromelain in the following dosage by weight: 15 mg to 90 mg amylase, 18 mg to 90 mg lactase and 6 mg to 80 mg bromelain. | 2010-06-10 |
| 20100143341 | THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions of general formula (I) comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 2010-06-10 |
| 20100143342 | BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES - A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, its production and its use a medicament, especially for the treatment of allergies. | 2010-06-10 |
| 20100143343 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ANTIBODY MEDIATED NEUROPATHIES - The use of a therapeutic capable of inhibiting complement, e.g., an anti-C5 antibody, to treat antibody mediated neuropathies is disclosed. | 2010-06-10 |
| 20100143344 | COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION - The present invention relates to methods and medicaments used for treating conditions that require axonal regeneration, e.g. in mammals affected by injury or disease of the central or peripheral nervous system. The medicaments used in these methods facilitate axonal regeneration by inhibition of the complement system. Conditions requiring axonal regeneration that may be treated in accordance with the invention include physical injuries as well as neurodegenerative disorders of the peripheral or central nervous system. | 2010-06-10 |
| 20100143345 | EPHA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF - The present invention relates to methods and compositions designed for the treatment, management, or prevention of cancer, particularly, metastatic cancer. The methods of the invention comprise the administration of an effective amount of one or more antibodies that bind to and agonize EphA2, thereby increasing EphA2 phosphorylation and decreasing EphA2 levels in cells which EphA2 has been agonized. The invention also encompasses antibodies that preferentially bind an EphA2 epitope exposed on cancer cells but not non-cancer cells. The invention also provides pharmaceutical compositions comprising one or more EphA2 antibodies of the invention either alone or in combination with one or more other agents useful for cancer therapy. | 2010-06-10 |
